Source: Υπουργείο Υγείας (CY) Revision Year: 2021 Publisher: Chiesi Hellas A.E.B.E., Geroulanou sq & 1, Renou Poggi str., 17455 Alimos, Greece
FLUIBRON 15 mg/5 ml syrup (0.3% w/v).
| Pharmaceutical Form |
|---|
|
Syrup. |
FLUIBRON 15 mg/5 ml syrup.
100 ml of syrup contain: ambroxol hydrochloride 0.300 g.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Ambroxol |
Ambroxol induces activation of the surfactant system by acting directly on the type II pneumocytes of the alveoles and the Clara cells in the region of the small airways. It promotes the formation and outward transfer of surface-active material in the alveolar and bronchial region of the foetal and adult lungs. |
| List of Excipients |
|---|
|
Liquid non-crystallizing sorbitol, glycerol, citric acid monohydrate, benzoic acid, sucralose, raspberry natural flavour, purified water. |
Internal packaging: type III glass, amber-coloured bottle with childproof cap and measuring cap.
Outer packaging: printed thin cardboard box.
Chiesi Hellas A.E.B.E., Geroulanou sq & 1, Renou Poggi str., 17455 Alimos, Greece
12668
22-02-1990 / 29-04-2011
| Drug | Countries | |
|---|---|---|
| FLUIBRON | Brazil, Cyprus, Turkey |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
